# NanoViricides, Inc. (NNVC)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/NNVC/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2025 | $ 0 | $ -8.52M | $ -3,816.97B | $ 0 | $ 11,071.72B |
| 2024 | $ 0 | $ -9.84M | $ -8.83M | $ 0 | $ 10.39M |
| 2023 | $ 0 | $ -10.12M | $ -6.71M | $ 0 | $ 12.45M |
| 2022 | $ 0 | $ -7.70M | $ -6.36M | $ 0 | $ 19.87M |
| 2021 | $ 0 | $ -10.36M | $ -8.21M | $ 0 | $ 26.47M |
| 2020 | $ 0 | $ -18.60M | $ -10.89M | $ 0 | $ 27.75M |
| 2019 | $ 0 | $ -10.12M | $ -8.08M | $ 1.06M | $ 7.72M |
| 2018 | $ 0 | $ -10.35M | $ -10.75M | $ 0 | $ 13.84M |
| 2017 | $ 0 | $ -14.14M | $ -8.43M | $ 5.16M | $ 15.92M |
| 2016 | $ 0 | $ -15.48M | $ -12.29M | $ 9.44M | $ 19.15M |
| 2015 | $ 0 | $ -7.37M | $ -11.26M | $ 7.86M | $ 28.38M |
| 2014 | $ 0 | $ -11.67M | $ -19.60M | $ 6.57M | $ 30.51M |
| 2013 | $ 0 | $ -19.67M | $ -12.83M | $ 3.74M | $ 10.21M |
| 2012 | $ 0 | $ -9.66M | $ -40.91M | $ 0 | $ 14.21M |
| 2011 | $ 0 | $ -9.31M | $ -5.98M | $ 0 | $ 12.39M |
| 2010 | $ 0 | $ -8.72M | $ -6.63M | $ 0 | $ 9.37M |
| 2009 | $ 0 | $ -4.65M | $ -3.48M | $ 0 | $ 4.35M |
| 2008 | $ 0 | $ -4.78M | $ -4.94M | $ 0 | $ 2.58M |
| 2007 | $ 0 | $ -4.00M | $ -4.06M | $ 0 | $ 2.12M |
| 2006 | $ 0 | $ -5.05M | $ -1.83M | $ 54.70M | $ 945.4K |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.11 |
| Current Ratio | 4.43 |

## Other views

- [Metrics](https://sponda.capital/en/NNVC.md)
- [Charts](https://sponda.capital/en/NNVC/charts.md)
- [Compare](https://sponda.capital/en/NNVC/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.